PriceTargets.com logo

Second Sight Medical Products - EYES Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 12/31/1969 07:45 PM ET
+0 (0.00%)
Get New Second Sight Medical Products Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EYES and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EYES

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Second Sight Medical Products in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for EYES for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Second Sight Medical Products. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/20/2020HC WainwrightReiterated RatingBuy$7.50High
12/13/2019Dougherty & CoInitiated CoverageBuy$6.00Medium
(Data available from 4/20/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/23/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/23/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
11/22/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/22/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/21/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
2/20/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
3/21/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/20/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Second Sight Medical Products logo
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $5.67
Low: $4.11
High: $13.05

52 Week Range

Now: N/A

Volume

36,800 shs

Average Volume

132,982 shs

Market Capitalization

$54.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.55

Frequently Asked Questions

What sell-side analysts currently cover shares of Second Sight Medical Products?

The following Wall Street research analysts have issued research reports on Second Sight Medical Products in the last twelve months: StockNews.com.
View the latest analyst ratings for EYES.

What is the current price target for Second Sight Medical Products?

0 Wall Street analysts have set twelve-month price targets for Second Sight Medical Products in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Second Sight Medical Products in the next year.
View the latest price targets for EYES.

What is the current consensus analyst rating for Second Sight Medical Products?

Second Sight Medical Products currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for EYES.

What other companies compete with Second Sight Medical Products?

Other companies that are similar to Second Sight Medical Products include Hyperfine, Precision Optics, electroCore, Movano and QT Imaging. Learn More about companies similar to Second Sight Medical Products.

How do I contact Second Sight Medical Products' investor relations team?

Second Sight Medical Products' physical mailing address is 12744 SAN FERNANDO ROAD SUITE 400, SYLMAR CA, 91342. The medical device company's listed phone number is (818) 833-5000 and its investor relations email address is [email protected]. The official website for Second Sight Medical Products is www.secondsight.com. Learn More about contacing Second Sight Medical Products investor relations.